1.20—Treatments for cardiovascular disease

Antihypertensives lower blood pressure; statins reduce cholesterol synthesis and LDL concentration; anticoagulants reduce clotting; platelet inhibitors reduce platelet aggregation. Each changes a different part of CVD risk.

A statin addresses long-term plaque risk, whereas an anticoagulant is relevant when unwanted clot formation is a concern. Beta blockers, vasodilators and diuretics lower pressure through different mechanisms.

A patient with high blood pressure and a high LDL concentration may need a different combination from a patient with an existing thrombus. Treatment choice depends on indication, benefit, contraindication and monitoring.

The same disease label can involve atherosclerosis, thrombosis or both. Matching mechanism to pathology prevents treating every cardiovascular problem as simply “high cholesterol”.

A drug reducing one risk factor does not erase all CVD risk, and benefits must be weighed against adverse effects. Do not infer a treatment recommendation from one measurement alone.